小型生物反應器市場 - 全球產業規模、佔有率、趨勢、機會和預測，按最終用戶、按產品（可重複使用的生物反應器、一次性生物反應器）、按地區和競爭分類，2019-2029F

2023 年全球小型生物反應器市場價值為15.2 億美元，預計到2029 年將穩定成長，複合年成長率為5.25%。的受控培養。它們對於生產疫苗、單株抗體和其他生物製藥產品至關重要。近年來，由於小型生物反應器的多功能性、成本效率以及對研究和開發工作的適用性，對小型生物反應器的需求顯著增加。

市場概況
預測期	2025-2029
2023 年市場規模	15.2億美元
2029 年市場規模	18.5億美元
2024-2029 年複合年成長率	5.25%
成長最快的細分市場	可重複使用的生物反應器
最大的市場	北美洲

由於生物製藥需求的不斷成長、生物加工技術的進步以及對個人化醫療的日益重視，這種激增推動了全球小型生物反應器市場的顯著成長。小型生物反應器，從台式到中試規模，專為滿足學術機構、研究實驗室和從事製程開發和有限規模生產的小型生物技術公司的要求而量身定做。這些生物反應器具有靈活性、可擴展性和使用者友善的操作等優點，已成為生物加工工作流程中不可或缺的資產。

主要市場促進因素

不斷成長的生物製藥行業正在推動全球小型生物反應器市場

對個人化醫療的需求不斷成長正在推動全球小型生物反應器市場

主要市場挑戰

成本限制

複雜的監管環境

主要市場趨勢

技術進步

細分市場洞察

產品洞察

最終使用者見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球小型生物反應器市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按最終用戶（製藥和生物製藥公司、CRO 和 CMO、學術和研究機構）
  • 副產物（可重複使用的生物反應器（不銹鋼生物反應器、玻璃生物反應器）、一次性生物反應器）
  • 按公司分類 (2023)
  • 按地區
• 市場地圖

第 6 章：北美小型生物反應器市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按最終用戶
  • 按產品分類
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第 7 章：歐洲小型生物反應器市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按最終用戶
  • 按產品分類
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第 8 章：亞太地區小型生物反應器市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按最終用戶
  • 按產品分類
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第 9 章：南美洲小型生物反應器市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按最終用戶
  • 按產品分類
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲小型生物反應器市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按最終用戶
  • 按產品分類
  • 按國家/地區
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 促進要素
• 挑戰

第 12 章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最近的發展

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第14章：競爭格局

• Sartorius AG
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Danaher Corp.
• Lonza Group Ltd.
• Eppendorf SE
• Miltenyi Biotec India Pvt Ltd.
• Getinge AB
• Solaris Biotech USA, Inc.
• Infors AG

第 15 章：策略建議

第16章調查會社について,免責事項

Global Small-scale Bioreactors Market was valued at USD 1.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. Bioreactors serve as indispensable equipment in biopharmaceutical manufacturing, facilitating the controlled cultivation of cells or microorganisms. They are vital for producing vaccines, monoclonal antibodies, and other biopharmaceutical products. Over recent years, there has been a notable uptick in demand for small-scale bioreactors owing to their versatility, cost efficiency, and suitability for research and development endeavors.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 1.52 Billion
Market Size 2029	USD 1.85 Billion
CAGR 2024-2029	5.25%
Fastest Growing Segment	Reusable Bioreactors
Largest Market	North America

This surge has propelled significant growth in the global market for small-scale bioreactors, spurred by the rising need for biopharmaceuticals, advancements in bioprocessing technology, and the growing emphasis on personalized medicine. Small-scale bioreactors, ranging from bench-top to pilot scale, are tailored to meet the requirements of academic institutions, research labs, and small biotech firms engaged in process development and limited-scale production. Offering benefits like flexibility, scalability, and user-friendly operation, these bioreactors have become indispensable assets in bioprocessing workflows.

Key Market Drivers

Growing Biopharmaceutical Industry is Driving the Global Small-scale Bioreactors Market

The biopharmaceutical industry is witnessing a remarkable surge, driven by advancements in biotechnology, increasing demand for personalized medicine, and the ongoing pursuit of innovative therapeutic solutions. Central to this flourishing industry are small-scale bioreactors, critical tools enabling efficient and cost-effective bioprocessing for research, development, and production. As the demand for biopharmaceuticals continues to escalate, the global small-scale bioreactors market is experiencing unprecedented growth, presenting lucrative opportunities for players across the value chain. The biopharmaceutical industry has emerged as a cornerstone of modern healthcare, offering novel treatments for a spectrum of diseases ranging from cancer to rare genetic disorders.

Biopharmaceuticals, derived from biological sources such as living cells or organisms, offer several advantages over traditional pharmaceuticals, including higher specificity, reduced side effects, and enhanced efficacy. There has been a substantial increase in research and development (R&D) activities focused on biologics, gene therapies, and cell-based therapies, propelling the demand for small-scale bioreactors. Small-scale bioreactors serve as indispensable tools in the biopharmaceutical development process, facilitating the cultivation of cells or microorganisms under controlled conditions. These reactors mimic the environment found in larger-scale bioprocessing facilities, allowing researchers and manufacturers to optimize parameters such as temperature, pH, oxygenation, and nutrient supply. Moreover, small-scale bioreactors enable efficient experimentation, process optimization, and scale-up, accelerating the transition from lab-scale to commercial production.

Rising Demand for Personalized Medicine is Driving the Global Small-scale Bioreactors Market

One of the primary drivers of the global small-scale bioreactors market is the increasing demand for personalized medicine. Unlike traditional one-size-fits-all approaches to healthcare, personalized medicine takes into account individual genetic variability, lifestyle factors, and environmental influences to develop targeted therapies that are tailored to the specific needs of each patient. This requires the ability to rapidly screen and test a wide range of drug candidates, optimize production processes, and scale up manufacturing in a cost-effective manner - all of which can be facilitated by small-scale bioreactor systems.

In drug discovery and development, small-scale bioreactors play a critical role in the screening and optimization of biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and cell-based therapies. By allowing researchers to simulate the conditions of larger bioreactors on a smaller scale, these systems enable high-throughput experimentation and process optimization, leading to faster development timelines and reduced R&D costs. Small-scale bioreactors are ideal for the production of niche or orphan drugs, which may have limited market potential but can offer significant clinical benefits to specific patient populations.

In addition to drug discovery and development, small-scale bioreactors are also being increasingly utilized in the manufacturing of personalized cell and gene therapies. These advanced therapies involve the manipulation of a patient's own cells or genetic material to treat or cure diseases, such as cancer, genetic disorders, and autoimmune conditions. Small-scale bioreactors allow researchers and manufacturers to culture patient-derived cells in a controlled environment, monitor their growth and differentiation, and optimize production processes to ensure product quality and consistency.

The growing adoption of small-scale bioreactors in personalized medicine is driving innovation and investment in the global bioprocessing industry. Companies are developing new technologies and solutions to meet the evolving needs of researchers and manufacturers, including integrated automation systems, disposable bioreactor platforms, and advanced analytics tools for process monitoring and control. Collaborations between academia, industry, and regulatory agencies are helping to establish best practices and standards for the development and manufacturing of personalized therapies, further accelerating the growth of the small-scale bioreactors market.

Key Market Challenges

Cost Constraints

Cost considerations remain a significant barrier to the widespread adoption of small-scale bioreactors. Despite their advantages in terms of reduced reagent consumption, shorter turnaround times, and lower facility requirements compared to traditional bioreactor systems, the initial investment and operating costs can still be prohibitive for many research and development organizations, especially smaller enterprises and academic institutions. Addressing cost constraints through technological advancements and strategic pricing models is crucial to expanding market access.

Complex Regulatory Landscape

Navigating the complex regulatory landscape presents another significant challenge for small-scale bioreactors. Biopharmaceutical development and production are subject to stringent regulations imposed by health authorities worldwide. Ensuring compliance with Good Manufacturing Practice (GMP) standards, documentation requirements, and validation protocols is essential but can be resource-intensive and time-consuming, particularly for smaller companies with limited regulatory expertise and infrastructure. Streamlining regulatory processes and providing comprehensive guidance tailored to small-scale bioreactor users could facilitate compliance and accelerate market adoption.

Key Market Trends

Technological Advancements

In recent years, the field of biotechnology has experienced remarkable growth, fueled by advancements in technology and increasing demand for biopharmaceuticals, personalized medicines, and biofuels. Among the key technologies driving this growth are small-scale bioreactors, which play a crucial role in the development and manufacturing of biopharmaceuticals and other biotechnology products. These compact and versatile systems have witnessed a surge in demand, thanks to their ability to mimic large-scale bioprocessing conditions, thereby accelerating research and development efforts. Technological advancements have led to the miniaturization of bioreactor systems, enabling researchers to conduct experiments on a smaller scale with greater precision and efficiency. Furthermore, automation features incorporated into these systems streamline processes, reduce manual intervention, and enhance reproducibility, thereby driving demand.

Modern small-scale bioreactors are equipped with advanced monitoring and control systems that enable real-time tracking of key parameters such as pH, temperature, dissolved oxygen, and agitation speed. These systems offer greater flexibility and control over the bioprocess, allowing researchers to optimize conditions for cell culture growth and product formation. Single-use bioreactor systems have gained traction in recent years due to their cost-effectiveness, scalability, and reduced risk of cross-contamination. Manufacturers are increasingly integrating single-use technologies into small-scale bioreactors, making them more accessible to researchers and facilitating seamless scale-up to larger production platforms. Innovations in cell culture techniques, such as perfusion bioreactors and microcarrier-based culture systems, have expanded the capabilities of small-scale bioreactors. These advancements enable the cultivation of a wide range of cell types, including mammalian cells, stem cells, and microbial cultures, for various applications in biopharmaceuticals, regenerative medicine, and tissue engineering.

Segmental Insights

Product Insights

Based on the category of product, Reusable Bioreactors emerged as the fastest growing segment in the global market for Small-scale Bioreactors in 2023. One of the key drivers behind the increasing adoption of reusable bioreactors is the growing emphasis on sustainability and environmental responsibility. Traditional single-use bioreactors generate significant amounts of plastic waste with each use, contributing to environmental pollution and resource depletion. In contrast, reusable bioreactors are designed to be sterilized and reused multiple times, significantly reducing waste generation and environmental impact. This sustainability aspect has become a crucial factor for companies striving to align with eco-friendly practices and reduce their carbon footprint.

Reusable bioreactors offer compelling cost advantages over single-use systems, particularly in the long term. While the initial investment for reusable bioreactors may be higher, their ability to be cleaned, sterilized, and reused multiple times results in significant cost savings over their lifecycle. Reusable bioreactors provide greater flexibility and scalability, allowing companies to adapt their manufacturing processes more efficiently to changing production requirements. This scalability is particularly advantageous for small-scale bioreactor applications, where rapid adjustments and cost-effectiveness are essential.

End User Insights

The Pharmaceutical & Biopharmaceutical Companies segment is projected to experience rapid growth during the forecast period. The pharmaceutical and biopharmaceutical industries have been at the forefront of adopting cutting-edge technologies to enhance drug discovery, development, and manufacturing processes. Small-scale bioreactors have emerged as indispensable tools in these sectors, enabling researchers and manufacturers to conduct experiments and produce biologics in controlled laboratory environments. These bioreactors offer several advantages, including precise monitoring and control of parameters such as temperature, pH, dissolved oxygen, and agitation speed, which are crucial for optimizing cell growth and product yield.

One of the key drivers behind the dominance of pharmaceutical and biopharmaceutical companies in the small-scale bioreactors market is the growing demand for biologics. Biologics, which include therapeutic proteins, monoclonal antibodies, vaccines, and gene therapies, have witnessed a significant increase in demand due to their effectiveness in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Small-scale bioreactors play a vital role in the development and production of these complex biologic drugs, allowing for rapid prototyping, process optimization, and scale-up.

Regional Insights

North America emerged as the dominant region in the global Small-scale Bioreactors market in 2023, holding the largest market share in terms of value. North America boasts a strong culture of innovation, with many leading biotech companies and research institutions driving advancements in bioprocessing technologies. These innovations result in the development of state-of-the-art small-scale bioreactors with enhanced capabilities and efficiency. The region is home to a flourishing biopharmaceutical sector, with numerous companies engaged in the research, development, and production of biologics. Small-scale bioreactors play a crucial role in biopharmaceutical manufacturing, from early-stage research to process optimization and scale-up, driving their widespread adoption in North America.

Key Market Players

Sartorius AG

Thermo Fisher Scientific Inc.

Merck KGaA

Danaher Corp.

Lonza Group Ltd.

Eppendorf SE

Miltenyi Biotec India Pvt Ltd.

Getinge AB

Solaris Biotech USA, Inc.

Infors AG

Report Scope:

In this report, the Global Small-scale Bioreactors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Small-scale Bioreactors Market, By End user:

Pharmaceutical & Biopharmaceutical Companies CROs & CMOs Academic & Research Institutes

Small-scale Bioreactors Market, By Product:

Reusable Bioreactors Single-use Bioreactors

Small-scale Bioreactors Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Small-scale Bioreactors Market.

Available Customizations:

Global Small-scale Bioreactors market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Small-scale Bioreactors Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By End user ( Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, Academic & Research Institutes)
  • 5.2.2. By Product (Reusable Bioreactors( Stainless Steel Bioreactors, Glass Bioreactors), Single-use Bioreactors)
  • 5.2.3. By Company (2023)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Small-scale Bioreactors Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By End user
  • 6.2.2. By Product
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Small-scale Bioreactors Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By End user
      • 6.3.1.2.2. By Product
  • 6.3.2. Mexico Small-scale Bioreactors Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By End user
      • 6.3.2.2.2. By Product
  • 6.3.3. Canada Small-scale Bioreactors Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By End user
      • 6.3.3.2.2. By Product

7. Europe Small-scale Bioreactors Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By End user
  • 7.2.2. By Product
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Small-scale Bioreactors Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By End user
      • 7.3.1.2.2. By Product
  • 7.3.2. Germany Small-scale Bioreactors Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By End user
      • 7.3.2.2.2. By Product
  • 7.3.3. United Kingdom Small-scale Bioreactors Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By End user
      • 7.3.3.2.2. By Product
  • 7.3.4. Italy Small-scale Bioreactors Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By End user
      • 7.3.4.2.2. By Product
  • 7.3.5. Spain Small-scale Bioreactors Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By End user
      • 7.3.5.2.2. By Product

8. Asia-Pacific Small-scale Bioreactors Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By End user
  • 8.2.2. By Product
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Small-scale Bioreactors Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By End user
      • 8.3.1.2.2. By Product
  • 8.3.2. India Small-scale Bioreactors Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By End user
      • 8.3.2.2.2. By Product
  • 8.3.3. South Korea Small-scale Bioreactors Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By End user
      • 8.3.3.2.2. By Product
  • 8.3.4. Japan Small-scale Bioreactors Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By End user
      • 8.3.4.2.2. By Product
  • 8.3.5. Australia Small-scale Bioreactors Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By End user
      • 8.3.5.2.2. By Product

9. South America Small-scale Bioreactors Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By End user
  • 9.2.2. By Product
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Small-scale Bioreactors Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By End user
      • 9.3.1.2.2. By Product
  • 9.3.2. Argentina Small-scale Bioreactors Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By End user
      • 9.3.2.2.2. By Product
  • 9.3.3. Colombia Small-scale Bioreactors Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By End user
      • 9.3.3.2.2. By Product

10. Middle East and Africa Small-scale Bioreactors Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By End user
  • 10.2.2. By Product
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Small-scale Bioreactors Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By End user
      • 10.3.1.2.2. By Product
  • 10.3.2. Saudi Arabia Small-scale Bioreactors Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By End user
      • 10.3.2.2.2. By Product
  • 10.3.3. UAE Small-scale Bioreactors Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By End user
      • 10.3.3.2.2. By Product

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Sartorius AG
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Thermo Fisher Scientific Inc.
• 14.3. Merck KGaA
• 14.4. Danaher Corp.
• 14.5. Lonza Group Ltd.
• 14.6. Eppendorf SE
• 14.7. Miltenyi Biotec India Pvt Ltd.
• 14.8. Getinge AB
• 14.9. Solaris Biotech USA, Inc.
• 14.10. Infors AG

15. Strategic Recommendations

16. About Us & Disclaimer